Drugs, Devices, and Diagnostics
Latest | Media coverage | Commentary | Academic Literature | Legislation | Reports and Government Documents
Covering prescription medicines and medical devices, which includes instruments, implants, scans and tests, as well as screening and health promoting interventions.
Latest
Media coverage
Explained: Why the Govt’s new gene tech shake-up is a big deal
The Government has just announced it’s ending what it calls a nearly 30-year ban on gene technology outside the lab. What does that mean? Science reporter Jamie Morton explains.
Influenza A: What is it, how serious is it and how long does it last?
This year, according to data from the Institute of Environmental Science and Research, the Auckland metropolitan area has had the most hospitalisations from influenza-like illness since 2015.
David Seymour’s ‘whole of society’ plan for tipping millions of dollars more in to Pharmac – and Big Pharma
The very idea of Pharmac presents a conundrum for the minister in charge, Act leader David Seymour.
Commentary
Tribunal releases report on Treaty Principles Bill
On Friday 16 August 2024, the Waitangi Tribunal released Ngā Mātāpono – The Principles: The Interim Report of the Tomokia Ngā Tatau o Matangireia – The Constitutional Kaupapa Inquiry Panel on The Crown’s Treaty Principles Bill and Treaty Clause Review Policies in pre-publication format.
Saving our med labs before they end up on the slab
Ian Powell formed his ideas of pathologists from watching too many crime dramas involving forensic pathologists. His favourite was CSI's Doc Robbins.
Academic Literature
The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand
Consistent with existing literature, we find that the level of frailty is significantly associated with the cost of healthcare. However, we find no association between drug burden and nonpharmaceutical/overall healthcare costs.
A realist evaluation of the development of extended pharmacist roles and services in community pharmacies
Four intermediate health service outcomes were identified: development of extended community pharmacist services; consumers using extended community pharmacist services; more integrated, collaborative primary health care services; and a fit-for-purpose community pharmacy workforce.
Pharmac should not be criticised simply for being selective and slow about the medicines it funds
Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused.
Legislation and Parliament
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Reports and Government Documents
Life since the pandemic: How the COVID-19 pandemic experience has shaped public attitudes and beliefs on public health, infectious disease and vaccination
Manatū Hauora | Ministry of Health. In June 2023, the Public Health Agency, within the Ministry of Health, commissioned research and evaluation agency Verian to undertake a series of research projects and population surveys into attitudes and behaviours related to...
Misuse of Drugs (Pseudoephedrine) Amendment Bill
Health Committee. In accordance with the Government’s commitment to allow the sale of cold and flu medication containing pseudoephedrine, the purpose of this Bill is to change the classification of pseudoephedrine as a controlled drug. This Bill reclassifies...
Revised Code of Practice for Diagnostic and Interventional Radiology ORS C1
The Radiation Safety Act 2016 (the Act) is administered by the Manatū Hauora – the Ministry of Health (the Ministry). Section 86(1) of the Act allows the Director for Radiation Safety (Director) to issue codes of practice. This is for the purpose of specifying technical requirements.
Key issues
HEALTH SERVICES AND SYSTEMS
EQUITY
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI